Janux Therapeutics, Inc.
USD15.70
+0.38 (+2.45%)
CEO
David Alan Campbell
IPO Date
2021-06-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.37
Prev. Close
$15.32
Day Low
$15.27
Day High
$15.76
52W Low
$12.12
52W High
$35.34
Market Cap
$0.96B
Volume
0.16M
| -41.7 |
| 31 Dec 2023 | FY | 75.8% | -721.2% | -16.9% | -15.3% | 0.07 | 26.80 | -8.1 |
| 31 Dec 2022 | FY | 90.2% | -732.2% | -19.7% | -17.3% | 0.08 | 20.14 | -8.7 |
| 31 Dec 2021 | FY | 100.0% | -898.3% | -8.9% | -8.6% | 0.00 | 29.46 | -24.9 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 46.3% | -41.8% | 0.00 | 5.05 | -154.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 53.3% | -624.0% | -0.50 | 0.14 | -247.0 |
| -6.7 |
| 30 Sept 2025 | Q3 | 95.0% | -243.1% | -2.5% | -2.4% | 0.02 | 35.86 | -15.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -3.4% | -3.3% | 0.02 | 47.03 | -10.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -2.3% | -2.2% | 0.02 | 58.47 | -17.7 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -2.0% | -1.9% | 0.02 | 59.21 | -37.6 |
| 30 Sept 2024 | Q3 | 100.0% | -6391.6% | -4.3% | -4.0% | 0.04 | 38.80 | -22.1 |
| 30 Jun 2024 | Q2 | 94.3% | -67.0% | -0.9% | -0.9% | 0.04 | 57.34 | -95.3 |
| 31 Mar 2024 | Q1 | 57.5% | -1178.9% | -2.3% | -2.1% | 0.04 | 62.09 | -31.3 |
| 31 Dec 2023 | Q4 | 78.4% | -477.8% | -3.4% | -3.1% | 0.07 | 26.80 | -10.7 |